Apr 22 |
With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
|
Apr 18 |
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
|
Apr 8 |
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
|
Apr 8 |
Here’s Why You Should Invest in Smith & Nephew plc (SNN)
|
Apr 4 |
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
|
Apr 3 |
Investors five-year losses continue as Smith & Nephew (LON:SN.) dips a further 5.6% this week, earnings continue to decline
|
Apr 1 |
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
|
Apr 1 |
Smith & Nephew PLC's Dividend Analysis
|
Mar 28 |
Smith & Nephew goes ex dividend Monday
|
Mar 25 |
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
|